YARS2 and cardiovascular disorder: Tyrosyl‐tRNA synthetase, mitochondrial (YARS2) is inhibited by tyrosine, its levels increase during aging, neurocognitive, metabolic, and cardiovascular disorders (Jhanji et al., 2022).